MiR-143 targets CTGF and exerts tumor-suppressing functions in epithelial ovarian cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNA-143 (miR-143) has been implicated in various cancers, but its role in epithelial ovarian carcinoma (EOC) is unclear.
• Understanding miR-143's function and mechanisms in EOC is crucial for developing new diagnostic and therapeutic strategies.

Purpose of the Study:

• To investigate miR-143 expression and its clinical significance in EOC.
• To elucidate the biological role and molecular mechanisms of miR-143 in EOC progression.

Main Methods:

• Quantitative real-time PCR to assess miR-143 expression in EOC tissues and cell lines.
• Cell proliferation, migration, and invasion assays to evaluate miR-143's functional role.
• Bioinformatic analysis and luciferase reporter assays to identify miR-143 targets.
• Western blotting and rescue experiments to validate the miR-143/CTGF interaction.

Main Results:

• miR-143 expression was significantly downregulated in EOC tissues and cell lines.
• Low miR-143 levels correlated with advanced FIGO stage, poor pathological grade, and lymph node metastasis.
• Overexpression of miR-143 suppressed EOC cell proliferation, migration, and invasion.
• Connective tissue growth factor (CTGF) was identified as a direct target of miR-143.
• CTGF expression was upregulated in EOC and inversely correlated with miR-143 levels.
• CTGF knockdown mimicked miR-143's suppressive effects, while CTGF restoration partially reversed them.

Conclusions:

• miR-143 acts as a tumor suppressor in EOC by inhibiting proliferation, migration, and invasion.
• The tumor-suppressive function of miR-143 is mediated, at least partly, through the downregulation of CTGF.
• miR-143 may serve as a potential diagnostic biomarker and therapeutic target for EOC.